George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here.
By insisting on taking HCQ when their was little to no benefits proven at the time the President may just have signed his own death warrant. As mentioned HCQ would appear to cause an adverse reaction when given with Interferons. Apparently he is having problems with his breathing. Should have supported SNG.
GPS- that’s a good call and thinking the same myself, 16 per cent is Floyd Magic in disguise. Both ramping hard either way depending on their current position. Both a waste of time with no useful posts between him. Still, everyone needs a hobby!.
We’ve heard from Skeletor, now we really need He Man. In his absence I’d just say that yourself or no one else here has a clue what’s going on behind the scenes. News any day wouldn’t surprise me as it’s a fast changing, dynamic situation. Predicting when and how big a rise in SP is pointless though I agree. I’m sure SNG are working as hard as they possibly can, we know they have the product and we know there is a great need. Hopefully the rest should fall into place. To say we will have to wait till Jan/Feb before significant news is highly unlikely imo.
Pity if Trump doesn’t take the drug that will give him a 79% chance of avoiding a ventilator. Still, he was happy to dismiss death rates and be a blatant non mask wearer. Kind of think he had it coming. Be great to get a shot of him tooting on a nebuliser.
Chris, she was yeah. I wrote to her a few months back now, never heard back though. I asked her what she thought about SNG001, and whether she thought interferon in a nebuliser would be a better administration than subcutaneous injection. That’s been answered now though really :)
The Chinese interferon would have been Alpha. They had advisors from Cuba who discovered the drug quite some time ago. Their was indeed reports at the start of the outbreak that healthcare workers were using a spray in China. I actually did a lot of research into interferons, with others on here, pre manic Monday and I recall a medical trial report ex vivo that stated their was a virtual 100% success rate with stopping viral replication when healthy cells were given interferon and the virus was then applied later. It made me think at the time could this be a shield from the virus if given as a prophylactic. Would be a very interesting research project that.
I appreciate trial data needs to be peer reviewed but if you do your research into SNG’s board and in particular Prof Holgate, I don’t think he has too many peers who could tie his shoelaces when it comes to respiratory diseases. Might sound blaise but it’s true. When the government needed someone to head up their recent investigation into how best to prepare for covid this winter who did Prof Whitty ask to chair the investigation? Yup Prof Holgate.
MAP agreement with Clinigen was announced yesterday TED. That piece to camera was probably filmed yesterday at the earliest. I’m not even sure the MAP is up and running as of today?. I contacted Clinigen to enquire about cost and availability, still waiting to hear back. I’ll post here if i do.
The doctor has to speak as she finds at the moment. We are waiting for usage approvals. How can she mention SNG001 when it currently is not quite available to her??. Trust me if she’s based at Southampton she knows about SNG001. Good find GKB regards French ATU approval. That starts on the 15th apparently and SYNAIRGEN up for the best tech award at the AIM awards on the 18th October. Should be lots more news flow to come.
Dexamethasone has been around since the 50’s and Remdesivir is owned by Gilead who probably have several senators in their back pocket. No great mystery they got fast tracked, certainly not down to them being more efficacious that’s for sure.
Splatted- it was a punt when it was pre hospital trial readout. It now has efficacy against Covid and COPD. Highly likely to be an effective all round anti viral so imo it isn’t a punt anymore. The punt, at the time, got rewarded from the 30p’s to £2.50. Clearly has retraced for now but you can’t hold a good share down for long!. Particularly when hospital admissions will go through the roof and people start asking what drugs do we have and not so centred on testing and vaccines which have taken up far too much money and media space this far, with zero impact.
Ok so we have a 10% price drop on the back of 3m shares being traded. Even if you said two thirds of those were sells which is definately arguable that would equate to roughly £2.9m in share sales. With the market cap being £210 million that means 10% drop equates to £21million in value. Doesn’t add up does it. Not saying anyone is playing games but it doesn’t make financial sense. I wouldn’t stop anyone from buying now. For me the drop is based on a perceived negative RNS when I think the opposite is true and absolutely doesn’t mean our hopes of partnerships/licensing deals are done with. Fundamentals of the drug and company haven’t changed.
Org- I really don’t view you badly at all, I don’t take anything on here too seriously which is probably for the best. I’ve never quite understood the more negative posters in general, if you’ve done your research and you are happy to invest your money then stick to your convictions but know that we can all get it wrong and we all need a bit of luck along the way. My faith in SNG has never waivered even when we were starring down the barrel at 35p. I hope they get the breaks with regulators etc, this is the current frustration but I’m certain if a drug and a company is due some breaks then SNG is it. Their is without doubt a pressing need, as today’s figures suggest. GLA
Seb/Org has said goodbye more times than two lovers waving each other off on a train platform. Let’s face it he loves being pedantic. It’s a better board when we discuss SNG. Afterall that’s why we are all here. Let’s hope for a better day tomorrow. I certainly don’t see today’s RNS as bad news in the slightest. Looks like the drug is going to be used for hospitalised patients in need and hopefully lead on to wider regulation and usage. Happy days.
I agree with John, the fact SNG haven’t attempted a raise when they had plenty of opportunity when SP was at £2 and above speaks volumes. FINNCAP no doubt would have urged them to do that (if it had been the plan) after manic Monday knowing full well that the SP was going to rocket. Instead we had a recent interview where RM stated SNG had always been in dialogue with big Pharma and to expect good news ‘fairly soon’. Shouldn’t be too long to wait imo.
Deal3r- I’m sure they changed the eligibility criteria too as now you can enter the trial if you have had symptoms for seven days or less. With around 6,000 infections a day they must be picking up some patients now. How many is anyone’s guess but it’s a national trial from multiple centres around the nation.
Bojo- that may be your idea of reality it certainly isn’t mine or others on here. There is a pressing need for this drug now. No other drugs thus far help much unless you are on deaths door. There are grounds for granting quicker market access due to the necessity of saving lives along the lines of ‘right to try’ access as they have in the states. Also this hasn’t been tested on a hundred people. It’s been tested on patients in Asthma, COPD and the hospitalised Covid trial. Enough numbers to match other drugs FDA expedited approvals in the past. I hope people keep the faith, we have good things coming soon.:)
Well it’s good to know the MM’s still have a sense of humour. :). More chance their being an RNS on Monday morning than them opening this up at 1.65p on Monday. They won’t hold this back when the RNS lands. No Lansdowne, Griffiths or Link to hold it back now either. American investors are here long term so don’t let them have your shares people. Good weekend all.